Actively Recruiting
A 3-day Course for CFS/ME
Led by Norwegian University of Science and Technology · Updated on 2025-11-26
100
Participants Needed
1
Research Sites
349 weeks
Total Duration
On this page
Sponsors
N
Norwegian University of Science and Technology
Lead Sponsor
U
University of Oslo
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem. In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures. There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed. If the 3-day course shows promising effects, this could have positive consequences for patients, relatives and health personnel, but also financially for the society and the municipality.
CONDITIONS
Official Title
A 3-day Course for CFS/ME
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with CFS/ME based on the Canada Consensus Criteria
- At least 50% out of school or work
- Ready to make changes in health or behavior (preparation phase)
- Provided informed consent to participate
You will not qualify if you...
- Physical illness or mental disorder that may explain symptoms, as assessed by a General Practitioner
- Suicide risk or previous suicide attempts
- Currently pregnant
- Bedridden and needing continuous care
- Insufficient Norwegian language skills to participate in the course and complete questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Psychology, NTNU
Trondheim, Norway
Actively Recruiting
Research Team
L
Leif Edward Ottesen Kennair, PhD prof
CONTACT
L
Live Landmark
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here